ArticleAmerican journal of translational research2019

BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.

Xueke Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.